Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. CooperSurgical pays $47m for IVF screener Reprogenetics
Cooper Cos. CooperSurgical subsidiary acquired in-vitro fertilization screening company Reprogenetics for nearly $47 million.
Livingston, N.J.-based Reprogenetics offers pre-implantation genetic screening and diagnosis for in vitro fertilization, Cooper said. The $46.5 million deal isn’t expected to affect earnings per share this year or in 2016, but should be accretive thereafter, the company said. Read more
2. Penumbra files for $115m IPO
Penumbra, fresh off its entrance into the peripheral vascular market, registered for an initial public offering worth $115 million.
Alameda, Calif.-based Penumbra also makes devices for treating neurovascular conditions including hemorrhagic and ischemic stroke. The company reported sales of $125.5 million last year, up 41.3% over 2013. Founded in 2004, Penumbra said it employs about 1,000 workers. Read more
1. FDA clears GE Healthcare’s low-dose lung cancer CT
GE Healthcare said the FDA granted it clearance for low-dose lung cancer screenings using its compatible computed tomography devices.
The Centers for Medicare and Medicaid services recommends the low-dose CT lung cancer screening and approved insurance reimbursement for high-risk patient beneficiaries who undergo the procedure, GE Healthcare said. Read more